|
1
|
ACS, . What are the key statistics about
brain and spinal cord tumors? 1 21–2016.Accessed 9/15/16.
http://www.cancer.org/cancer/braincnstumorsinadults/detailedguide/brain-and-spinal-cord-tumors-in-adults-key-statistics
|
|
2
|
ABTA (American Brain Tumor Association), .
Brain Tumor Facts. Last revised 12/2015. 9 15–16.http://www.abta.org/about-us/news/brain-tumor-statistics
|
|
3
|
Yurchenco PD and Schittny JC: Molecular
architecture of basement membranes. FASEB J. 4:1577–1590.
1990.PubMed/NCBI
|
|
4
|
Barsky SH, Siegal GP, Jannotta F and
Liotta LA: Loss of basement membrane components by invasive tumors
but not by their benign counterparts. Lab Invest. 49:140–147.
1983.PubMed/NCBI
|
|
5
|
Liotta LA, Tryggvason K, Garbisa S, Hart
I, Foltz CM and Shafie S: Metastatic potential correlates with
enzymatic degradation of basement membrane collagen. Nature.
284:67–68. 1980. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Forsyth PA, Laing TD, Gibson AW, Rewcastle
NB, Brasher P, Sutherland G, Johnston RN and Edwards DR: High
levels of gelatinase-B and active gelatinase-A in metastatic
glioblastoma. J Neurooncol. 36:21–29. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jäälinojä J, Herva R, Korpela M, Höyhtyä M
and Turpeenniemi-Hujanen T: Matrix metalloproteinase 2 (MMP-2)
immunoreactive protein is associated with poor grade and survival
in brain neoplasms. J Neurooncol. 46:81–90. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Smith ER, Zurakowski D, Saad A, Scott RM
and Moses MA: Urinary biomarkers predict brain tumor presence and
response to therapy. Clin Cancer Res. 14:2378–2386. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
de Visser KE and Coussens LM: The
inflammatory tumor microenvironment and its impact on cancer
development. Contrib Microbiol. 13:118–137. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Coussens LM and Werb Z: Inflammation and
cancer. Nature. 420:860–867. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Germano G, Allavena P and Mantovani A:
Cytokines as a key component of cancer-related inflammation.
Cytokine. 43:374–379. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Allavena P, Garlanda C, Borrello MG, Sica
A and Mantovani A: Pathways connecting inflammation and cancer.
Curr Opin Genet Dev. 18:3–10. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gridley DS, Loredo LN, Slater JD,
Archambeau JO, Bedros AA, Andres ML and Slater JM: Pilot evaluation
of cytokine levels in patients undergoing radiotherapy for brain
tumor. Cancer Detect Prev. 22:20–29. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhou W, Jiang Z, Li X, Xu Y and Shao Z:
Cytokines: Shifting the balance between glioma cells and tumor
microenvironment after irradiation. J Cancer Res Clin Oncol.
141:575–589. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ilyin SE, González-Gómez I, Romanovicht A,
Gayle D, Gilles FH and Plata-Salamán CR: Autoregulation of the
interleukin-1 system and cytokine-cytokine interactions in primary
human astrocytoma cells. Brain Res Bull. 51:29–34. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ryuto M, Ono M, Izumi H, Yoshida S, Weich
HA, Kohno K and Kuwano M: Induction of vascular endothelial growth
factor by tumor necrosis factor alpha in human glioma cells.
Possible roles of SP-1. J Biol Chem. 271:28220–28228. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Esteve PO, Tremblay P, Houde M, St-Pierre
Y and Mandeville R: In vitro expression of MMP-2 and MMP-9 in
glioma cells following exposure to inflammatory mediators. Biochim
Biophys Acta. 1403:85–96. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Niedzwiecki A, Roomi MW, Kalinovsky T and
Rath M: Micronutrient synergy - a new tool in effective control of
metastasis and other key mechanisms of cancer. Cancer Metastasis
Rev. 29:529–542. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rath M and Pauling L: Plasmin-induced
proteolysis and the role of apoprotein(a), lysine and synthetic
analogs. Orthomolecular Med. 7:17–23. 1992.
|
|
21
|
Sun Z, Chen YH, Wang P, Zhang J, Gurewich
V, Zhang P and Liu JN: The blockage of the high-affinity lysine
binding sites of plasminogen by EACA significantly inhibits
prourokinase-induced plasminogen activation. Biochim Biophys Acta.
1596:182–192. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mussini E, Hutton JJ Jr and Udenfriend S:
Collagen proline hydroxylase in wound healing, granuloma formation,
scurvy, and growth. Science. 157:927–929. 1967. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kivirikko KI and Myllylä R: Collagen
glycosyltransferases. Int Rev Connect Tissue Res. 8:23–72. 1979.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Valcic S, Timmermann BN, Alberts DS,
Wächter GA, Krutzsch M, Wymer J and Guillén JM: Inhibitory effect
of six green tea catechins and caffeine on the growth of four
selected human tumor cell lines. Anticancer Drugs. 7:461–468. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mukhtar H and Ahmad N: Tea polyphenols:
Prevention of cancer and optimizing health. Am J Clin Nutr. 71
Suppl 6:S1698S–S1704S. 2000.
|
|
26
|
Yang GY, Liao J, Kim K, Yurkow EJ and Yang
CS: Inhibition of growth and induction of apoptosis in human cancer
cell lines by tea polyphenols. Carcinogenesis. 19:611–616. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Taniguchi S, Fujiki H, Kobayashi H, Go H,
Miyado K, Sadano H and Shimokawa R: Effect of (−)-epigallocatechin
gallate, the main constituent of green tea, on lung metastasis with
mouse B16 melanoma cell lines. Cancer Lett. 65:51–54. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hara Y: Green Tea: Health Benefits and
Applications. Marcel Dekker; New York, Basel: 2001, http://dx.doi.org/10.1201/9780203907993
View Article : Google Scholar
|
|
29
|
Gupta S, Hastak K, Afaq F, Ahmad N and
Mukhtar H: Essential role of caspases in
epigallocatechin-3-gallate-mediated inhibition of nuclear factor
kappa B and induction of apoptosis. Oncogene. 23:2507–2522. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fujiki H, Suganuma M, Okabe S, Sueoka E,
Suga K, Imai K, Nakachi K and Kimura S: Mechanistic findings of
green tea as cancer preventive for humans. Proc Soc Exp Biol Med.
220:225–228. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kawakami S, Kageyama Y, Fujii Y, Kihara K
and Oshima H: Inhibitory effect of N-acetylcysteine on invasion and
MMP-9 production of T24 human bladder cancer cells. Anticancer Res.
21:213–219. 2001.PubMed/NCBI
|
|
32
|
Morini M, Cai T, Aluigi Mg, Noonan DM,
Masiello L, De Flora S, D'Agostini F, Albini A and Fassina G: The
role of the thiol N-acetylcysteine in the prevention of tumor
invasion and angiogenesis. Int J Biol Markers. 14:268–271.
1999.PubMed/NCBI
|
|
33
|
Yoon SO, Kim MM and Chung AS: Inhibitory
effect of selenite on invasion of HT1080 tumor cells. J Biol Chem.
276:20085–20092. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cha J, Roomi MW, Ivanov V, Kalinovsky T,
Niedzwiecki A and Rath M: Ascorbate supplementation inhibits growth
and metastasis of B16FO melanoma and 4T1 breast cancer cells in
vitamin C-deficient mice. Int J Oncol. 42:55–64. 2013.PubMed/NCBI
|
|
35
|
Naidu KA, Karl RC, Naidu KA and Coppola D:
Antiproliferative and proapoptotic effect of ascorbyl stearate in
human pancreatic cancer cells: Association with decreased
expression of insulin-like growth factor 1 receptor. Dig Dis Sci.
48:230–237. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Anthony HM and Schorah CJ: Severe
hypovitaminosis C in lung-cancer patients: The utilization of
vitamin C in surgical repair and lymphocyte-related host
resistance. Br J Cancer. 46:354–367. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Maramag C, Menon M, Balaji KC, Reddy PG
and Laxmanan S: Effect of vitamin C on prostate cancer cells in
vitro: Effect on cell number, viability, and DNA synthesis.
Prostate. 32:188–195. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Koh WS, Lee SJ, Lee H, Park C, Park MH,
Kim WS, Yoon SS, Park K, Hong SI, Chung MH, et al: Differential
effects and transport kinetics of ascorbate derivatives in leukemic
cell lines. Anticancer Res. 18:2487–2493. 1998.PubMed/NCBI
|
|
39
|
Chen Q, Espey Mg, Krishna MC, Mitchell JB,
Corpe CP, Buettner GR, Shacter E and Levine M: Pharmacologic
ascorbic acid concentrations selectively kill cancer cells: Action
as a pro-drug to deliver hydrogen peroxide to tissues. Proc Natl
Acad Sci USA. 102:13604–13609. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Núñez M, artín C, de Apodaca y Ruiz A
Ortiz and Ruiz A: Ascorbic acid in the plasma and blood cells of
women with breast cancer. The effect of the consumption of food
with an elevated content of this vitamin. Nutr Hosp. 10:368–372.
1995.(In Spanish). PubMed/NCBI
|
|
41
|
Kurbacher CM, Wagner U, Kolster B,
Andreotti PE, Krebs D and Bruckner HW: Ascorbic acid (vitamin C)
improves the antineoplastic activity of doxorubicin, cisplatin, and
paclitaxel in human breast carcinoma cells in vitro. Cancer Lett.
103:183–189. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Cooke JP and Dzau VJ: Nitric oxide
synthase: Role in the genesis of vascular disease. Annu Rev Med.
48:489–509. 1997. View Article : Google Scholar : PubMed/NCBI
|
